Patents by Inventor Keith Richard Lorimer

Keith Richard Lorimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CLOPIDOGREL SALT AND POLYMORPHIC FORMS THEREOF
    Publication number: 20100227882
    Abstract: The invention relates to methyl(+)-(S)-?-(2-chlorophenyl)-6,7-dihydrothieno[3,2-C]pyridine-5(4H) acetate naphthalene-1,5-disulfonate or a polymorphic form and/or a hydrate and/or a solvate thereof, to pharmaceutical compositions containing the same, and to the method of use thereof for inhibiting platelet aggregation.
    Type: Application
    Filed: January 26, 2010
    Publication date: September 9, 2010
    Applicant: sanofi-aventis
    Inventors: Keith Richard LORIMER, Alicia Tee Fuay NG
  • Clopidogrel salt and polymorphic forms thereof
    Patent number: 7652139
    Abstract: The invention relates to methyl(+)-(S)-?-(2-chlorophenyl)-6,7-dihydrothieno[3,2-C]pyridine-5(4H) acetate naphthalene-1,5-disulfonate or a polymorphic form and/or a hydrate and/or a solvate thereof, to pharmaceutical compositions containing the same, and to the method of use thereof for inhibiting platelet aggregation.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: January 26, 2010
    Assignee: sanofi-aventis
    Inventors: Keith Richard Lorimer, Alicia Tee Fuay Ng
  • PHARMACEUTICAL SOLID STATE FORMS
    Publication number: 20090291932
    Abstract: The invention provides and describes solid state 17?-ethynyl-5?-androstane-3?,17?-diol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-5?-androstane-3?,17?-diol include Form III anhydrate and Form I solvate. The invention further relates to solid and suspension formulations containing 17?-ethynyl-5?-androstane-3?,17?-diol in a described solid state form and use of the formulations to treat cancers or precancers such as prostate cancer or breast cancer in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-5?-androstane-3?,17?-diol and uses of such formulations in treating the described conditions.
    Type: Application
    Filed: February 12, 2009
    Publication date: November 26, 2009
    Applicant: HollisEden Pharmaceuticals, INC.
    Inventors: Steven K. White, Dwight Stickney, Erin Olson, Keith Richard Lorimer, Brenton Skylar Wolfe